Gene therapy in 2025 from vector design to regulation
Gene therapy is moving from specialist promise to established practice in 2025. Approvals have broadened across indications, clinical data in Huntington’s disease have shifted expectations for neurology, and regulators have formalised flexible pathways for small populations. In parallel, precision editing and vector engineering are reducing risk and improving targeting. The result is a credible pathway […]